0 CHECKOUT

Eisai Inc. - Strategic SWOT Analysis Review

  • ID: 1495870
  • May 2016
  • 34 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Abraxis BioScience, Inc.
  • Adlyfe Inc.
  • AstraZeneca PLC
  • Ceregene, Inc.
  • Koronis Pharma, Inc.
  • White River Health System
  • MORE

Eisai Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – our summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abraxis BioScience, Inc.
  • Adlyfe Inc.
  • AstraZeneca PLC
  • Ceregene, Inc.
  • Koronis Pharma, Inc.
  • White River Health System
  • MORE

List of Tables

List of Figures

Section 1 - About the Company

Eisai Inc. - Key Facts

Eisai Inc. - Key Employees

Eisai Inc. - Key Employee Biographies

Eisai Inc. - Major Products and Services

Eisai Inc. - History

Eisai Inc. - Company Statement

Eisai Inc. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Eisai Inc. - Business Description

Eisai Inc. - Corporate Strategy

Eisai Inc. - SWOT Analysis

SWOT Analysis - Overview

Eisai Inc. - Strengths

Strength - Strong In-house Research Expertise

Strength - Product Collaboration with Leading Players

Strength - Marketed Products

Eisai Inc. - Weaknesses

Weakness - Weak Financial Performance

Eisai Inc. - Opportunities

Opportunity - Rising Healthcare Expenditure in the US

Opportunity - Strategic Initiatives

Opportunity - Strategic Partnerships

Opportunity - Orphan Drug Designation

Eisai Inc. - Threats

Threat - Intense Competition

Threat - Stringent Government Regulations

Threat - Litigation Claims

Eisai Inc. - Key Competitors

Section 3 – Company’s Lifesciences Financial Deals and Alliances

Eisai Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Eisai Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Eisai Inc., Recent Deals Summary

Section 4 – Company’s Recent Developments

Apr 20, 2016: Dr. Avinash Desai appointed Vice President, Americas Oncology Medical Affairs, Oncology Business Group at Eisai

Apr 11, 2016: Beyhan Zaim appointed Vice President Commercial Development & Alzheimer's Disease Global Lead, Neurology Business Group at Eisai

Apr 06, 2016: Paul Hawthorne appointed Senior Vice President, U.S. Commercial, Neurology Business Group at Eisai

Mar 30, 2016: Global Drug Maker Eisai Signs Three-Year Contract Extension For CSC’s Total Regulatory Solution as-a-Service

Oct 28, 2015: BVGH Accelerates R&D for Neglected Diseases through WIPO Re:Search Collaborations

Jul 16, 2015: Eisai Enters Agreement to Transfer Its Research Triangle Park Campus to Biogen

Jun 01, 2015: Ivor Macleod Appointed Senior Vice President, Chief Financial Officer and Chief Compliance Officer of Eisai

Apr 09, 2015: Eisai Realigns U.S. Operations

Section 5 – Appendix

Methodology

About us

Contact Us

Disclaimer

List of Tables

Eisai Inc., Key Facts

Eisai Inc., Key Employees

Eisai Inc., Key Employee Biographies

Eisai Inc., Major Products and Services

Eisai Inc., History

Eisai Inc., Other Locations

Eisai Inc., Subsidiaries

Eisai Inc., Key Competitors

Eisai Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Eisai Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Eisai Inc., Recent Deals Summary

List of Figures

Eisai Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Eisai Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Note: Product cover images may vary from those shown
3 of 4

Wellstat Therapeutics Corporation
Research Foundation for Mental Hygiene, Inc
White River Health System
Salix Pharmaceuticals Ltd.
Koronis Pharma, Inc.
Abraxis BioScience, Inc.
Adlyfe Inc.
Predictive Biosciences, Inc.
AstraZeneca PLC
Ceregene, Inc.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.